Celyad SA (CYAD): Price and Financial Metrics


Celyad SA (CYAD)

Today's Latest Price: $10.35 USD

0.53 (-4.87%)

Updated Dec 13 6:55pm

Add CYAD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 325 in Biotech

See all "A" rated Strong Buy stocks

CYAD Stock Summary

  • With a price/sales ratio of 34.58, Celyad Sa has a higher such ratio than 96.62% of stocks in our set.
  • With a year-over-year growth in debt of 303.59%, Celyad Sa's debt growth rate surpasses 94.18% of about US stocks.
  • As for revenue growth, note that CYAD's revenue has grown 2,060.55% over the past 12 months; that beats the revenue growth of 99.56% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Celyad Sa, a group of peers worth examining would be PRQR, MRUS, ARPO, MDWD, and STML.
  • Visit CYAD's SEC page to see the company's official filings. To visit the company's web site, go to www.celyad.com.
CYAD Daily Price Range
CYAD 52-Week Price Range

CYAD Stock Price Chart More Charts


CYAD Price/Volume Stats

Current price $10.35 52-week high $25.36
Prev. close $10.88 52-week low $8.10
Day low $10.31 Volume 114,200
Day high $10.90 Avg. volume 20,183
50-day MA $10.09 Dividend yield N/A
200-day MA $14.76 Market Cap 102.18M

Celyad SA (CYAD) Company Bio


Celyad SA is a leader in engineered cell therapy treatments with clinical programs initially targeting indications in cardiology and oncology. The company was founded in 2004 and is based in Mont-Saint-Guibert, Belgium.





CYAD Latest News Stream


Event/Time News Detail
Loading, please wait...

CYAD Latest Social Stream


Loading social stream, please wait...

View Full CYAD Social Stream

CYAD Price Returns

1-mo 19.24%
3-mo 3.09%
6-mo -14.30%
1-year -48.64%
3-year -42.98%
5-year N/A
YTD -43.01%
2018 -57.87%
2017 142.68%
2016 -67.47%
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5524 seconds.